236 Studies Now Enrolling
Menu
Search
Medical Condition
- Show all (236)
- Addiction (3)
- Allergy, Asthma, & Immunology (1)
- Autoimmune Disorders (3)
- Bone & Muscle (2)
- Cancer (10)
- COVID-19 (Coronavirus) (8)
- Diabetes (7)
- Ear, Nose and Throat (7)
- (-) Endocrine & Metabolic Disease (2)
- Gastrointestinal and Digestive Diseases (3)
- Hair and Skin Disorders (1)
- Healthy Volunteers (45)
- Heart Disease (18)
- Infectious Disease (11)
- Insomnia (1)
- Liver Disease (17)
- Lung Disease (2)
- Neurological Disorders (30)
- Nutrition (2)
- Obesity (8)
- Obstetrics & Gynecology (10)
- Pediatrics (15)
- Psychiatric Disorders (9)
- Rehabilitation (2)
- Stroke (2)
- Transplant (16)
- Vascular Conditions (1)
Displaying 1 - 5 of 5
Condition: Liver Disease / Cirrhosis of the Liver
Investigator: Giuseppe Cullaro, MD
Status: Currently Recruiting
Researchers at Columbia University Irving Medical Center are investigating whether PHIN-24 is safe and tolerable after single and multiple ascending doses for people with advanced cirrhosis. Advanced liver cirrhosis is the late stage of chronic liver scarring, where the liver has lost most of its ability to function normally. Study participants will: 1) Be…
Condition: Liver Disease / Cirrhosis of the Liver
Investigator: Julia Wattacheril, MD, MPH
Status: Currently Recruiting
The purpose of this research study is to determine how well BI3802876 is tolerated in people living with cirrhosis due to a liver condition called metabolic dysfunction-associated steatohepatitis (MASH, formerly known as NASH). The study medication, BI3802876, is investigational, meaning it has not yet been approved by the United States Food and Drug…
Condition: Endocrine & Metabolic Disease
Investigator: Joshua Cook, MD, PhD
Status: Currently Recruiting
We are recruiting volunteers, aged 18-70 without diabetes, for a research study on determining how much of the blood sugar- lowering hormone insulin the body can produce in order to better identify people at risk for diabetes in the future. To do this, we will have approximately 15 participants stay for approximately 30 hours (including overnight) in the…
Condition: Liver Disease / Cirrhosis of the Liver
Investigator: Elizabeth Verna, MD
Status: Currently Recruiting
The purpose of this research study is to determine whether rosuvastatin is safe and can help people living with cirrhosis lead longer, healthier lives. The study drug, rosuvastatin, is investigational, meaning it has not yet been approved for market use for this disease condition by the United States Food and Drug Administration (FDA). Participants will…
Condition: Endocrine & Metabolic Disease
Investigator: Joshua Cook, MD, PhD
Status: Currently Recruiting
We are conducting a research study on the effect of high insulin levels on the buildup of excessive liver fat ("fatty liver disease") in people at risk for type 2 diabetes. We are seeking adult volunteers, ages 18-65, who have obesity with a body mass index of 30-45, and have been diagnosed with, or are at risk for, prediabetes and metabolic…